ALK-Abelló A/S ALK-Abelló A/S

ALK-Abelló A/S

ALK-B

Rank in Stocks #2336
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
Share Price
$37.76
Market Cap
$8.38B
Change (1 day)
-0.08%
Change (1 year)
12.64%
Country
DK
Trade ALK-Abelló A/S (ALK-B)

Category

Healthcare
Stock split history for ALK-Abelló A/S (ALK-B)
ALK-Abelló A/S stock (symbol: ALK-B) underwent a total of 1 stock splits.
The most recent stock split occurred on Mar 28, 2022.
One ALK-B share bought prior to Mar 28, 2022 would equal to 20 ALK-B shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2022-03-28 20:1 x20 x20
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL